PBLS PARABILIS MEDICINES INC revenue, earnings and financials
For the quarter ended June 30, 2026, PARABILIS MEDICINES INC reported revenue of $148K, net income of −$52.5M and diluted EPS of −$2.32.
PBLS quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $148K, net income −$52.5M, EPS −$2.32
- Quarter ended Mar 31, 2026: revenue n/a, net income −$45.3M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $0, net income −$34.8M, EPS −$22.28
- Quarter ended Mar 31, 2025: revenue n/a, net income −$38.3M, EPS n/a
PBLS balance sheet
- Jun 30, 2026: cash $1.09B, total assets $1.18B, total liabilities $128M, shareholders' equity $1.05B, long-term debt $700K
- Dec 31, 2025: cash $27.7M, total assets $80.8M, total liabilities $97.3M, shareholders' equity −$526M, long-term debt $600K